This document provides an overview of gingival enlargement (gingival overgrowth). It begins with definitions and classifications, including by etiology, location/distribution, and degree. The main types discussed are inflammatory (chronic, acute), drug-induced, idiopathic, and those associated with systemic diseases. Neoplastic and false enlargements are also covered. Clinical features and treatments are described for various conditions like chronic inflammatory, drug-induced by anticonvulsants/immunosuppressants, leukemia, and peripheral giant cell granuloma. Surgical treatments include scaling, root planing, gingivoplasty and gingivectomy using conventional, electrosurgery, laser, or

2. CONTENTS
 INTRODUCTION
-DEFINITION
-CLASSIFICATION
-GRADING
 INFLAMMATORY GINGIVAL
ENLARGEMENT
 DRUG-INDUCED
 IDIOPATHIC
 ENLARGEMENTS ASS. WITH
SYSTEMIC DISEASES
 NEOPLASTIC
 FALSE ENLARGEMENT
 TREATMENT

3. INTRODUCTION
DEFINITION
Increase in size of gingiva is called as gingival
enlargement (Gingival overgrowth).
Carranza’s 11 th edition

4. CLASSIFICATION
According to etiologic factors and pathologic changes-
1.Inflammatory enlargement
a. Chronic
b. Acute
2.Drug-induced enlargement
1.Anticonvulsants
2.Immunosuppressants
3. Calcium channel blockers
3.Enlargements associated with systemic diseases or conditions
A)Conditioned enlargement
i)Pregnancy
ii)Puberty
iii)Vitamin C deficiency
iv)Plasma cell gingivitis
v)Non specific conditioned enlargement(pyogenic
granuloma)

5. B.)Systemic diseases causing gingival enlargement
i)Leukemia
ii)Granulomatous disease(Wegener’s
granulomatosis, sarcoidosis)
4.Neoplastic enlargement
a) Benign tumors
b) Malignant tumors
5.False enlargement

6. According To Location And Distribution
LOCALIZED GENERALIZED

7. Degree Of Gingival Enlargement
Grade 0- No signs of gingival enlargement
Grade 1 - Enlargement confined to interdental papilla
Grade 2 - Enlargement involves papilla
and marginal gingiva
Grade 3 - Enlargement covers three quarters or
more of the crown

8. CHRONIC INFLAMMATORY
ENLARGEMENT
ACUTE INFLAMMATORY ENLARGEMENT
(GINGIVAL ABSCESS)
CLINICAL FEATURES-
Ballooning of interdental papilla &
marginal gingiva
Localized or generalized
Progresses slowly & painlessly
Site- Interdental papilla, marginal &
attached gingiva
CLINICAL FEATURES
Localized, painful, rapidly expanding
lesions
Lesion becomes fluctuant & pointed with
surface orifice within 24-48 hrs
Site- Limited to marginal gingiva or
interdental papilla
ETIOLOGY-
Prolonged exposure to dental plaque
Poor oral hygiene
Anatomic abnormalities
Improper restorative & orthodontic
appliance
ETIOLOGY
Bacteria carried deep into tissues with a
foreign substance forcefully embedded into
gingiva
TYPES OF GINGIVAL INFLAMMATORY ENLARGEMENT

9. Drug-induced gingival enlargement
Gingival enlargement is a well known consequence of administration of
drugs such as
Anticonvulsants
Immunosuppressants
Calcium channel blockers
Clinical features
1. Painless, beadlike enlargement of the interdental papilla and extends to
facial and lingual gingival margins
2. Maxillary & mandibular anterior regions
3. When uncomplicated by inflammation is mulberry shaped, firm,pale
pink, and resilient , with a minutely lobulated surface and no tendancy
to bleed
4. Project from beneath the gingival margin

10. SYSTEMIC USE Treatment of all
forms of epilepsy
except petit mal
Prevent organ
transplant
rejection & several
autoimmune
diseases
Treatment of
cardiovascular
conditions such as
hypertension,
angina pectoris &
cardiac arrythmias
DRUGS SPECIFIC
TO CAUSE
GINGIVAL
ENLARGEMENT
Phenytoin Cyclosporine Nifedipine
Pathogenesis Phenytoin stimulates
proliferation of
fibroblasts like cells
and epithelium
Formation of
abundant
extracellular matrix
as a hypersensetivity
response
Prevalence Gingival
enlargement occurs
in 50% of patients
receiving phenytoin
Cyclosporine
causes gingival
enlargement in 25%-
70% patients
Nifedipine induces
gingival enlargement
in 20% of patients
DRUGS ANTICONVULSANTS IMMUNOSPRESSANTS Ca CH.BLOCKER

11. IDIOPATHIC GINGIVAL ENLARGEMENT
Rare condition of undetermined cause.
CLINICAL FEATURES
-Affects the attached gingiva as well as the gingival margin and interdental
papilla
-Involment is limited to the either jaw
-Enlarged gingiva is pink, firm and almost leathery in consistency
-Characterstic minutely pebbled surface

12. ENLARGEMENTS ASSOCIATED WITH
SYSTEMIC DISEASES
Systemic diseases and conditions can affect the periodontium by two
different mechanisms-
1. Magnification of an existing inflammation initiated by dental
plaque(conditioned enlargement)
2. Manifestation of the systemic disease independently of the
inflammatory status of the gingiva.

13. CONDITIONED ENLARGEMENT
HORMONAL Vit.C DEFICIENCY ALLERGIC
CLINICAL FEATURES
1. Generalized
2. Prominent
interproximally
3. Bright red or magenta
4. Soft and friable & has
smooth & shiny surface
5. Bleeds spontaneously
CLINICAL FEATURES
1. Marginal
2. Bluish red
3. Soft & friable & smooth
& shiny surface
4. Spontaneous bleeding
5. Surface necrosis with
pseudomembrane
formation
CLINICAL FEATURES
1. Frequent in women &
young adults
2. Located on oral aspect
of attached gingiva &
therefore differs from
plaque induced
gingivitis.

14.  Female are affected more than male
 Common age of occurrence is 11-40 yrs
 Its size ranges from 0.9- 2 cm.
 Asymptomatic, may be papular or nodular Polypoid mass.
 It may become mature and becomes less vascular and more collagenous gradually
converting into a fibrous epulis.
CLINICAL FEATURES
NON SPECIFIC CONDITIONED ENLARGEMENT
(PYOGENIC GRANULOMA)
Lesions are elevated pedunculated or sessile
masses with smooth lobulated or even warty.
Surface is commonly ulcerated and shows
tendency to hemorrhage upon slightest pressure or trauma.
 Variegated red and white pattern.

15. SYSTEMIC DISEASES CAUSING GINGIVAL ENLARGEMENT
GRANULOMATOUS DISEASE
(WEGENER’S GRNULOMATOSIS)
CLINICAL FEATURES
1. Leukemic enlargement may be diffuse or
marginal localized or generalized.
2. The gingiva becomes soft, edematous and
swollen.
3. Appearance of gingiva is purplish and glossy.
4. There is also pallor in the surrounding mucosa.
5. Ulceration pain and severe hemorrhage can also
occur.
6. It has a spongy consistency and bleeds
CLINICAL FEATURES
1. It involve the orofacial region and include oral
mucosal ulceration, gingival enlargement,
abnormal tooth mobility, exfoliation of teeth,
and delayed healing response.
2. “Strawberry gums” appearance of the
mandibular gingiva is commonly seen.
3. Enlargement is reddish purple and bleeds easily
on stimulation but the condition is considered an
LEUKEMIA

16. NEOPLASTIC ENLARGEMENT
(GINGIVAL TUMORS)
BENIGN
Fibroma
Papilloma
Peripheral giant
cell granuloma
Central giant
cell granuloma
Leukoplakia
Gingival cyst
MALIGNANT
Carcinoma
Malignant
melanoma

17. BENIGN TUMORS
FIBROMA PAPILLOMA
PERIPHERAL GIANT
CELL GRANULOMA
GINGIVAL CYST

18. MALIGNANT TUMORS
CLINICAL FEATURES
1. Common in 5th and 6th decade of life.
2. Carcinoma of mandibular gingiva is more
common
3. The fixed gingiva is invaded more than the free
gingiva.
4. It usually occurs in premolar area.
5. Quickly spreads from gingiva to alveolar bone
CLINICAL FEATURES
1. Malignant melanoma is a rare oral tumor that
tends to occur in the hard palate and maxillary
gingiva of older persons.
2. It is usually darkly pigmented and is often
preceded by localized pigmentation.
3. It may be flat or nodular and is characterized by
rapid growth and early metastasis.
4. It arises from melanoblasts in the gingiva,
cheek, or palate.
CARCINOMA MALIGNANT MELANOMA

19. FALSE ENLARGEMENT
UNDERLYING OSSEOUS LESION
1. Enlargement of the bone subjacent to the
gingival area occur most often in tori and
exostoses.
2. It can also occur in paget’s disease,
fibrous dysplasia, cherubism, central
giant cell granuloma, ameloblastoma,
osteoma and osteosarcoma.
UNDERLYING DENTAL TISSUES
During various stages of eruption
particularly of the primary dentition, the
labial gingiva may show a bulbous
marginal distortion caused by
superimposition of the bulk of the
gingiva on the normal prominence of the
enamel in the gingival half of the crown.

21. • Scaling
• Root planning
• Oral hygiene
instructions
PHASE I
THERAPY
• Gingivoplasty
• GingivectomyPHASE II
THERAPY
TREATMENT PLAN

22. GINGIVECTOMY
• Pockets are explored & marked with pocket
marker
• External bevel incision- 45˚ to tooth surface
• Curette granulation tissue
• Surgical pack
Conventional
• Pockets marked with a pocket marker
• Enlarged tissue removed using needle
electrode.
Electrosurgery
• Diode laser and Nd:YAG LASERS
• They have wavelength of 890 nm and
1064 nm.Laser
Methods of external bevel gingivectomy
• 5% formaldehyde or potassium
hydroxide can be usedChemosurgery